NASDAQ: ACIU
Ac Immune Sa Stock Forecast, Predictions & Price Target

Analyst price target for ACIU

Based on 1 analyst offering 12 month price targets for Ac Immune Sa

Min Forecast
$16.00+981.08%
Avg Forecast
$16.00+981.08%
Max Forecast
$16.00+981.08%

Should I buy or sell ACIU stock?

Based on 1 analyst offering ratings for Ac Immune Sa.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ACIU's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates ACIU as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their ACIU stock forecasts and price targets.

ACIU stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-03

1 of 1

Forecast return on equity

Is ACIU forecast to generate an efficient return?

Company
5.1%
Industry
147.71%
Market
81.76%
ACIU's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ACIU forecast to generate an efficient return on assets?

Company
2.48%
Industry
35.52%
ACIU is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ACIU earnings per share forecast

What is ACIU's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.50
Avg 2 year Forecast
-$0.79
Avg 3 year Forecast
-$0.28

ACIU revenue forecast

What is ACIU's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$36.5M+20.34%
Avg 2 year Forecast
$24.5M-19.36%
Avg 3 year Forecast
$115.2M+279.72%
ACIU's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ACIU revenue growth forecast

How is ACIU forecast to perform vs Biotechnology companies and vs the US market?

Company
47.35%
Industry
65.42%
Market
10.4%
ACIU's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ACIU's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ACIU vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ACIU$1.48$16.00+981.08%Buy
SLN$3.14$40.80+1,199.36%Buy
KOD$2.84$9.00+216.90%Hold
CYBN$7.35$86.00+1,070.07%Strong Buy
PPBT$2.84$33.00+1,061.97%Buy

Ac Immune Sa Stock Forecast FAQ

Is Ac Immune Sa Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ACIU) stock is to Buy ACIU stock.

Out of 1 analyst, 0 (0%) are recommending ACIU as a Strong Buy, 1 (100%) are recommending ACIU as a Buy, 0 (0%) are recommending ACIU as a Hold, 0 (0%) are recommending ACIU as a Sell, and 0 (0%) are recommending ACIU as a Strong Sell.

If you're new to stock investing, here's how to buy Ac Immune Sa stock.

What is ACIU's earnings growth forecast for 2025-2027?

(NASDAQ: ACIU) Ac Immune Sa's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.37%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.2%.

Ac Immune Sa's earnings in 2025 is -$56,573,333.On average, 3 Wall Street analysts forecast ACIU's earnings for 2025 to be -$49,873,834, with the lowest ACIU earnings forecast at -$86,352,924, and the highest ACIU earnings forecast at $22,090,283. On average, 3 Wall Street analysts forecast ACIU's earnings for 2026 to be -$79,655,552, with the lowest ACIU earnings forecast at -$99,406,273, and the highest ACIU earnings forecast at -$60,246,226.

In 2027, ACIU is forecast to generate -$28,114,906 in earnings, with the lowest earnings forecast at -$110,451,415 and the highest earnings forecast at $16,065,660.

What is ACIU's revenue growth forecast for 2025-2027?

(NASDAQ: ACIU) Ac Immune Sa's forecast annual revenue growth rate of 47.35% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 65.42%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.4%.

Ac Immune Sa's revenue in 2025 is $30,343,333.On average, 3 Wall Street analysts forecast ACIU's revenue for 2025 to be $3,666,585,327, with the lowest ACIU revenue forecast at $456,867,215, and the highest ACIU revenue forecast at $10,041,037,700. On average, 2 Wall Street analysts forecast ACIU's revenue for 2026 to be $2,457,041,925, with the lowest ACIU revenue forecast at $1,731,074,899, and the highest ACIU revenue forecast at $3,183,008,951.

In 2027, ACIU is forecast to generate $11,569,283,638 in revenue, with the lowest revenue forecast at $11,195,757,036 and the highest revenue forecast at $11,942,810,240.

What is ACIU's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: ACIU) forecast ROA is 2.48%, which is lower than the forecast US Biotechnology industry average of 35.52%.

What is ACIU's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ACIU price target, the average ACIU price target is $16.00, with the highest ACIU stock price forecast at $16.00 and the lowest ACIU stock price forecast at $16.00.

The Wall Street analyst predicted that Ac Immune Sa's share price could reach $16.00 by Apr 3, 2026. The average Ac Immune Sa stock price prediction forecasts a potential upside of 981.08% from the current ACIU share price of $1.48.

What is ACIU's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: ACIU) Ac Immune Sa's current Earnings Per Share (EPS) is -$0.57. On average, analysts forecast that ACIU's EPS will be -$0.50 for 2025, with the lowest EPS forecast at -$0.86, and the highest EPS forecast at $0.22. On average, analysts forecast that ACIU's EPS will be -$0.79 for 2026, with the lowest EPS forecast at -$0.99, and the highest EPS forecast at -$0.60. In 2027, ACIU's EPS is forecast to hit -$0.28 (min: -$1.10, max: $0.16).

What is ACIU's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: ACIU) forecast ROE is 5.1%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.